Unlocking $80,000 in Savings: The Overlooked Power of Genomic Sequencing in U.S. Healthcare
Despite advanced medical technologies, delayed diagnoses in children with neurological conditions create high costs and emotional strain. Genomic sequencing, a powerful diagnostic tool, is underutilized early in care, prolonging ineffective treatments and emergency interventions. Early use of genomic testing has been shown to reduce healthcare costs dramatically—by up to 61% for epilepsy—shifting treatment towards more effective and cost-efficient outpatient care. This approach especially benefits Medicaid, which often covers complex cases. The main challenge is uneven implementation, not technology availability. Expanding access to genomic sequencing can improve outcomes and reduce expenses, making it a crucial priority in healthcare reform.
Generare Secures €20M to Unlock the Secrets of Microbial Chemistry
Generare, a Paris techbio company, has raised €20 million to advance its work decoding the complex molecular structures found in microbial genomes. With groundbreaking progress in discovering novel molecules for drug development, the company is positioning itself as a leader in the field. The Series A round was co-led by venture firms Alven and Daphni.
The Reality and Promise of AI in Drug Discovery: Beyond the Hype
AI in drug discovery is progressing rapidly, speeding up early-stage development and improving candidate quality. Still, biology's complexity limits AI’s ability to fully replace traditional methods. Recent successes demonstrate real potential, but the revolution is gradual rather than instantaneous.
Innovative Deep-Tech Entrepreneur Harnessing AI to Tackle Immunology Issues
Camille Bouget highlights how AI is revolutionizing innovation in immunology, offering new possibilities for treating diseases that affect the immune system.
FDA Approves Eli Lilly's New Obesity Drug, Sparking Competition with Novo Nordisk
Eli Lilly's new obesity treatment has received FDA approval, marking a significant development in obesity management and setting the stage for competition with Novo Nordisk's Wegovy. This approval could influence market dynamics and patient options in the obesity drug industry.
MP Challenges Palantir's Assertion that NHS Deal Criticism Is 'Ideologically Driven'
Chi Onwurah, leading a parliamentary committee, rejected Palantir's accusation that criticism over their £330m NHS contract is ideologically motivated. She highlighted the government's rightful measures to seek advice on ending the agreement.
HHS Renames U.S. Health IT Office and Expands Its Role
The U.S. Department of Health and Human Services has renamed the federal health IT office back to the Office of the National Coordinator under the Trump administration, indicating changes to its scope and authority in managing national health IT policies.
How AI-Driven Startups in the Northeast Are Revolutionizing Healthcare
Northeast-based startups are leveraging AI to improve healthcare delivery by monitoring patients more effectively, expediting case evaluations, and supporting faster clinical decisions, marking a significant advancement in medical technology.
Palantir UK's Head Defends NHS Partnership Amid Calls for Contract Termination
Palantir UK's leader urges government to uphold a £330m NHS contract despite pressures from ideological campaigners and challenges regarding the company's role in public sector data projects.
Mantis Biotech Develops Human Digital Twins to Tackle Medicine’s Data Shortage
Mantis Biotech addresses the challenge of limited medical data by constructing synthetic datasets that form detailed digital twins of human bodies, encompassing anatomy, physiology, and behavior. This innovation facilitates enhanced medical studies and treatment development.
Job Growth Slows at Major For-Profit Health Insurers Amid Medicaid Cuts
Employment growth is stalling among the largest for-profit health insurers as they cut jobs. Meanwhile, potential Medicaid funding reductions may prompt hospital layoffs, indicating a tightening job market in healthcare.
Blossom Health Secures $20 Million to Enhance Telepsychiatry with AI Support
Blossom Health, a New York telepsychiatry startup founded in 2024, raised $20 million in early funding to grow its AI-powered platform that supports psychiatrists with clinical copilots and automation. The round was led by Headline, whose partner Mathias Schilling is now on Blossom Health's board, marking a significant step in combining AI with mental health care.
OpenUp Secures €20M to Expand Employee Mental Health Services Across Europe
OpenUp, an Amsterdam startup offering employees anonymous mental health support via employers, has raised €20 million to grow its presence across Europe. The platform currently serves more than 2,000 organizations and provides easy access to psychologists, lifestyle experts, and financial counselors. Investors include Smartfin and Rubio Impact Ventures. This funding round aims to modernize the conventional path to professional psychological help in European workplaces.
€36 Million Fund Supports 341 Groundbreaking Research Initiatives
Over €36 million in funding will support 341 innovative research projects focused on cancer treatments, sustainable food solutions, and energy-efficient batteries, promoting progress in health, sustainability, and energy technology.
Advancing Behavioral Health Through Enhanced Technology
Behavioral health faces rising demand and challenges like clinician burnout and outdated technology. Progress includes reduced stigma and increased treatment rates, but legacy systems create inefficiencies. Next-generation EHRs focusing on interoperability, AI assistance, and outcomes reporting are essential for better care coordination, reduced administrative burdens, and improved decision-making. Enhanced technology will drive sustainable growth and improved patient outcomes in behavioral health.
JAAQ Secures $17M to Expand Clinically-Backed Mental Health Solutions in Popular Digital Platforms
JAAQ, a London digital health platform serving 1.5 million users, has raised $17M in Series A funding to accelerate its US expansion and enhance clinical oversight under a new CEO with notable experience.
Opinion: Building Trust is Essential for AI in Healthcare
Oni Blackstock emphasizes that healthcare's adoption of AI must focus on building trust among patients and providers rather than accelerating investments. A careful, transparent approach is necessary to prevent worsening medicine's existing trust challenges.
Addressing the U.S. Healthcare Crisis: Innovative Actions by Companies and Nonprofits Ahead of Federal Policy Reforms
The U.S. faces a worsening healthcare crisis marked by rising costs and medical debt. Nonprofits and businesses are stepping in with innovative solutions, but experts agree that significant federal policy reforms are essential. Efforts include medical debt relief, cost reduction in specialty care, and legal challenges. Advocacy and systemic change are critical to making meaningful progress.
Harnessing AI in Healthcare Marketing: Strategies, Tools, and Real-World Successes for 2026
AI is revolutionizing healthcare marketing by enhancing personalization, predictive analytics, and patient engagement while posing compliance challenges. This guide details strategies, tools, and examples from 2026 demonstrating how healthcare organizations successfully integrate AI to boost revenue and improve patient trust and outcomes.
Perplexity Debuts Perplexity Health, Bridging AI with Apple Health Ecosystem
Perplexity has launched Perplexity Health, integrating Apple Health, wearables, and electronic health records into its AI platform. This positions the company as a key player in the rapidly growing consumer health AI market, second only to OpenAI in Apple Health integration.